Stay updated on Atrasentan in IgA Nephropathy Clinical Trial

Sign up to get notified when there's something new on the Atrasentan in IgA Nephropathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atrasentan in IgA Nephropathy Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T19:08:23.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    A general NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page. The site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-27T18:45:52.000Z thumbnail image
  3. Check
    28 days ago
    Change Detected
    Summary
    The footer now identifies the site revision as v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-06T21:36:25.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the normal study-record content with an access-denied message and the site footer.
    Difference
    0.5%
    Check dated 2026-09-29T20:49:51.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content with an access-denied notice. The header/navigation remains visible, indicating restricted access to the page.
    Difference
    19%
    Check dated 2026-09-22T22:20:57.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now displays revision v3.7.0, replacing the previous v3.6.6 tag. This indicates a metadata/version update rather than a change to study information.
    Difference
    0.0%
    Check dated 2026-09-15T21:38:52.000Z thumbnail image

Stay in the know with updates to Atrasentan in IgA Nephropathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atrasentan in IgA Nephropathy Clinical Trial page.